SNAP Tests versus Reference Lab ELISA for Feline Retrovirus Screening

1. Introduction

Feline leukemia virus (FeLV) and feline immunodeficiency virus (FIV) are two clinically significant retroviruses of domestic cats [1]. Screening for these pathogens is a cornerstone of feline preventive medicine, and the diagnostic market offers two dominant platform categories: point-of-care (POC) immunochromatographic lateral flow assays (commonly called SNAP-type tests) and reference laboratory enzyme-linked immunosorbent assays (ELISAs) [1, 2]. Both platforms detect viral antigens (FeLV p27) or host antibodies (anti-FIV gp40/p24) depending on the target, but they differ fundamentally in format, analytical sensitivity, throughput, and cost [2]. A detailed understanding of these differences is essential for clinicians and diagnostic laboratorians when choosing a screening strategy.

2. Biophysical and Chemical Principles of the Assay Formats

2.1 Immunochromatographic Lateral Flow (SNAP-type) Assays

Point-of-care SNAP-type tests are typically membrane-based, single-use cassettes that rely on capillary flow of sample through a nitrocellulose strip [1]. The sample (whole blood, plasma, or serum) is mixed with a conjugated detection antibody labelled with a visible chromogen (e.g., colloidal gold or colored latex beads) [1]. As the mixture migrates, the analyte (FeLV p27 antigen or anti-FIV antibodies) binds to the conjugate. The complex is captured by an immobilized capture antibody at a test line. A second control line ensures flow validity. Results are read visually within 10 to 20 minutes [1].

The principle for FeLV detection is a sandwich immunoassay for p27 antigen [1]. For FIV detection, the test uses an indirect format: the sample's anti-FIV antibodies are captured by immobilized FIV antigen (typically recombinant p24 or gp40) and then detected by an anti-feline immunoglobulin conjugate [1]. The limit of detection (LOD) for lateral flow assays is generally higher than that of plate-based ELISA, typically in the nanogram per milliliter range due to the short reaction time and single-pass binding [2].

2.2 Plate-Based Enzyme-Linked Immunosorbent Assay (ELISA)

Reference laboratory ELISAs are microtiter plate formats that use sequential incubation steps, wash cycles, and enzyme-mediated signal amplification [2]. For FeLV p27 antigen detection, a sandwich ELISA is used: the plate is coated with anti-p27 monoclonal antibodies, sample is added, and after washing, a second enzyme-labelled anti-p27 antibody is applied. Substrate conversion yields a colorimetric or fluorescent signal proportional to antigen concentration [2]. For FIV antibody detection, an indirect ELISA is employed where recombinant FIV antigens are adsorbed to the plate, and patient antibodies are detected with an anti-feline IgG enzyme conjugate [2]. The use of multiple wash steps and enzyme amplification pushes the LOD into the picogram per milliliter range, offering superior analytical sensitivity compared to lateral flow [2].

3. Comparative Diagnostic Performance

3.1 Analytical Sensitivity and Specificity

Numerous studies have compared the two formats. For FeLV p27 detection, reference laboratory ELISA demonstrates higher analytical sensitivity than SNAP-type tests, with a lower limit of detection often by a factor of 10-100 [1, 2]. This translates into a slightly lower false-negative rate in early infection when viral antigen levels are low [1]. However, the clinical significance of such marginal differences is debated, as laterally flow tests are designed to detect antigen levels associated with viremia [1].

For FIV antibody detection, both platforms show excellent sensitivity, but reference laboratory ELISAs can occasionally detect seroconversion slightly earlier [2]. Specificity is high for both methods, though SNAP-type tests have been reported to yield rare false positives due to non-specific binding from hemolyzed or lipemic samples [1]. Reference laboratory ELISAs, with their wash steps, reduce such matrix effects [2].

3.2 Clinical Sensitivity in Field Populations

Clinical sensitivity is influenced by disease stage and viral load. In a population of cats with progressive FeLV infection (persistent antigenemia), both SNAP-type and ELISA tests achieve near-perfect agreement [1]. In cats with regressive infection (transient antigenemia or latent provirus), antigen levels may fall below the LOD of lateral flow but remain detectable by ELISA for a short window [1, 2]. For FIV, antibody levels wane in end-stage immunodeficiency, but both formats typically remain positive until terminal stages [2].

A summary of key comparative parameters is provided in Table 1.

Table 1. Comparison of SNAP-type Lateral Flow and Reference Laboratory ELISA for Feline Retrovirus Screening

4. Workflow and Clinical Decision Making

The choice between a SNAP-type test and a reference laboratory ELISA depends on clinical context. For emergency screening or in-clinic decision making (e.g., before vaccination, blood transfusion, or adoption), the speed of lateral flow assays is advantageous [1]. For confirmatory testing, for low-prevalence populations where specificity is paramount, or for quantitative monitoring of antigen levels, reference laboratory ELISA is preferred [2].

Many practices use a two-step algorithm: an initial in-clinic SNAP-type test, followed by submission of positive or equivocal samples to a reference laboratory for ELISA (or proviral PCR) confirmation [1, 2]. This approach balances timeliness with accuracy.

Mermaid Diagram: Recommended Retrovirus Screening Algorithm

flowchart TD
    A[Cat presents for retrovirus screening], > B{Perform in-clinic SNAP-type test}
    B, > |FeLV or FIV negative| C[Report negative. No further testing unless recent exposure]
    B, > |FeLV or FIV positive| D[Collect serum/plasma and send to reference lab]
    D, > E[Reference lab ELISA for FeLV p27 or FIV antibody]
    E, > |Positive| F[Confirm progressive infection. Provide counseling.]
    E, > |Negative or equivocal| G[Consider PCR for proviral DNA / viral RNA]
    G, > H[Interpret based on infection category]

5. Limitations and Pitfalls

Both testing platforms have inherent limitations. SNAP-type tests are subject to operator variability in interpreting weak lines, especially near the visual detection threshold [1]. Additionally, the short incubation time may not allow complete binding of low-affinity antibodies, reducing sensitivity in early FIV infection [2]. Reference laboratory ELISAs, while more sensitive, require sample transportation which delays results and risks sample degradation [1]. Furthermore, the ELISA signal can be affected by high background if the anti-feline conjugate cross-reacts with heterophilic antibodies [2].

Vaccination history must be considered. Killed FIV vaccines (where available) induce antibodies that are detectable by both ELISA and SNAP-type tests, leading to false-positive results for several months post-vaccination [1]. FeLV vaccines do not interfere with p27 antigen detection because they contain inactivated virus but not soluble p27 [2]. To clarify true infection status in FIV-vaccinated cats, confirmatory proviral PCR or Western blotting is required [1].

6. Frequently Asked Questions

What are the primary structural differences between a SNAP-type test and a reference lab ELISA?

SNAP-type tests are lateral flow immunochromatographic devices using one-step capillary migration on a nitrocellulose membrane, while ELISAs use multi-step, batch-processed microtiter plates with wash steps and enzyme amplification [1, 2].

Which format has higher analytical sensitivity for FeLV p27 antigen?

Reference laboratory ELISA has a lower limit of detection (picogram range) compared to lateral flow (nanogram range) [2].

Can a negative SNAP-type test rule out FeLV or FIV infection?

A negative SNAP-type test essentially rules out progressive FeLV infection (persistent p27 antigenemia) and active FIV antibody-positive status. However, in very early infection (FeLV) or end-stage immunodeficiency (FIV), false negatives are possible [1]. If exposure is suspected within the previous 30-60 days, retesting via ELISA or PCR is recommended [1, 2].

Why do some cats test positive on SNAP but negative on reference lab ELISA?

This discrepancy may result from non-specific binding in the lateral flow format, especially with hemolyzed or lipemic samples [1]. Reference laboratory ELISAs, with wash steps, are more specific. Conversely, a rare false-positive on ELISA due to cross-reactivity has also been documented [2].

Should vaccinated cats be tested with a SNAP-type test or ELISA?

For FIV-vaccinated cats, both tests will detect vaccine-induced antibodies and will yield positive results for up to a year after vaccination [1]. Confirmatory testing with a proviral PCR (which detects viral DNA) is necessary to distinguish vaccination from infection [2]. FeLV vaccination does not interfere with p27 antigen detection in either platform [1].

How does sample type affect test performance?

SNAP-type tests are validated for whole blood, plasma, or serum [1]. Whole blood can cause higher background due to cellular debris. Reference laboratory ELISAs almost exclusively use serum or plasma, which reduces matrix interference [2].

What is the role of proviral PCR in the context of these serological tests?

Proviral PCR detects integrated FeLV or FIV DNA in host cells and can identify infected cats that are antigen- or antibody-negative, especially in regressive FeLV infection or early FIV seroconversion [1]. It is often used as a confirmatory test after discrepant serology results [2].

References

[1] Greene CE. Infectious Diseases of the Dog and Cat. 4th ed. Elsevier; 2012.

[2] Lutz H, Addie D, Belák S, et al. Feline leukaemia virus. ABCD guidelines on prevention and management. Journal of Feline Medicine and Surgery. 2009;11(7):565-574. *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.